Shwachman Diamond Syndrome Registry and Study

Phase

N/A

Condition

Pancreatitis

Pancreatic Disorders

Aplastic Anemia

Treatment

N/A

Clinical Study ID

NCT06056908

P00020466

All Genders

Study Summary

Shwachman-Diamond syndrome (SDS) is a genetic condition characterized by bone marrow failure, medical co-morbidities, and leukemia predisposition. SDS-Like patients share clinical features with SDS but lack mutations in known SDS genes. Since SDS/SDS-Like syndromes are rare diseases, data are sparse regarding the clinical features, natural history, clinical outcomes with current management, and treatment. For this reason, the SDS Registry was formed to collect clinical data from medical records and to bank biological samples with the goal of understanding SDS/SDS-Like diseases to develop better treatments and improve the health of patients with these conditions.

Eligibility Criteria

Inclusion

Inclusion Criteria: Shwachman Diamond syndrome, Shwachman-Diamond Syndrome-Like conditions,or a genetically undefined condition that shares clinical features with Shwachman DiamondSyndrome.

Biallelic mutations in SBDS, or pathogenic mutations in DNAJC21, EFL1, or SRP54 OR
Shwachman-Diamond Syndrome defined clinically OR
Clinically suspected Shwachman-Diamond Syndrome OR
Phenotypic features suggestive of SDS OR
Parents, siblings, and other blood relatives of any age, living and deceased, ofpatients with SDS or SDS-Like conditions are eligible for this study

Exclusion

Exclusion Criteria:

• Patients with other diagnosed causes of bone marrow failure, exocrine pancreaticinsufficiency and cancer predisposition will be excluded.

Study Design

January 19, 2016

January 01, 2090

Study Description

The Shwachman-Diamond Syndrome Registry (SDSR) is dedicated to accelerating research and treatment for SDS to improve survival and quality of life for all patients with the disease. The SDSR is run jointly by Boston Children's Hospital and Cincinnati Children's Hospital Medical Center.

Objective and Aims:

The long term goals of the Registry are to improve diagnosis, inform medical management, and to develop better treatments for SDS and SDS-Like disorders.

To achieve these objectives, the Registry has the following specific aims:

Characterize the natural history, medical complications, and treatment outcomes for patients with SDS and SDS-Like disorders.
Investigate the molecular and genetic pathogenesis of SDS/SDS-Like conditions and their complications such as marrow failure and clonal evolution.
Identify new genes causing SDS/SDS-Like conditions.
Provide education on the diagnosis, medical management and treatment of SDS for patients, families and the medical/scientific community.

Methods: The SDSR collects information from medical records and biological samples. Samples for the SDSR are collected when they are obtained for clinical care so that no extra visits or procedures are needed. These samples may include blood, bone marrow, skin cells, saliva, or discards from other clinical procedures. Family members may also contribute blood samples. All information obtained by the SDSR is housed on a secure, HIPAA-compliant database. No personal information is shared outside of the study team.

Connect with a study center

Children's Hospital Colorado
Aurora, Colorado 80045
United States
Active - Recruiting
Boston Children's Hospital
Boston, Massachusetts 02115
United States
Active - Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts 02115
United States
Active - Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229
United States
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.